Concepedia

Matthew S. Corbett

MS

Statistics

Publications

12

Citations

494

H-Index

12

Active since

2003

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Boston University

Molecular Discovery (United Kingdom)

Matthew S. Corbett is an author at Pfizer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2003–2018

12

Publications

12

Design of Selective, ATP-Competitive Inhibitors of Akt

Kevin D. Freeman‐Cook, Christopher Autry, Gary Borzillo et al. · Journal of Medicinal Chemistry · 2010 · 77 citations · Full text

, , +17

Synthesis and structure based optimization of novel Akt inhibitors

Blaise Lippa, Gonghua Pan, Matthew S. Corbett et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations · Full text

, , +12

Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors

Sharan K. Bagal, Kiyoyuki Omoto, David C. Blakemore et al. · Journal of Medicinal Chemistry · 2018 · 53 citations · Full text

, , +15

Discovery of novel isothiazole inhibitors of the TrkA kinase: Structure–activity relationship, computer modeling, optimization, and identification of highly potent antagonists

Blaise Lippa, Joel Morris, Matthew S. Corbett et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 47 citations · Full text

, , +16

Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain

Sharan K. Bagal, Mark D. Andrews, Bruce M. Bechle et al. · Journal of Medicinal Chemistry · 2018 · 39 citations · Full text

, , +15

1–5 of 12